” LumenXT Names Marc Beer as its New Chairman of the Board “

LumeNXT recently announced Marc Beer as the newly appointed Chairman of the Board. The company is privately-held and specializes in the development of a surgical illumination product line designed to enhance surgeries that have a minimally invasive approach. The focuses on pioneering the use of LED illumination for intracavity purposes, the company’s illumination platform being used as a mechanism in order to improve safety, efficiency and precision via enhanced visualization.

 

Surgeons who have used targeted illumination noted that this technology is able to enhance flexibility, precision and visualization during operations. The illumination platform offered by LumeNXT is used as a heat reduction mechanism, this being designed to improve low-cost disposable option, as well as surgical precision, as well as safety.

 

Marc Beer talked about his new role in the company, noting that he is proud to be working with LumeNXT’s group of surgeons and engineers, describing them as dedicated and accomplished, as they advanced the field of surgical illumination by using the company’s technology. The new Chairman of the Board also stated that he considers that the platform’s importance will increase, given that more surgeries get performed using minimally invasive approaches.

 

The company’s co-founder, Paul Rhyne, also commented on the appointment of Marc Beer as the Chairman of the Board, stating that he demonstrated high levels of success within the startup companies that he has guided through phases of growth. The co-founder went on to highlight the fact that Beer has experience in starting and guiding companies to profitability, noting that his experience is highly valued at LumeNXT, as the company is growing.

 

The new Chairman of the Board brings over 25 years of experience in development and commercialization areas in sectors such as pharmaceuticals, diagnostics, devices, and biotechnology. Besides his new role at LumeNXT, Marc Beer is also the co-founder and the Chief Executive Officer of Renovia, Inc. The company was founded in August of 2016, and specializes in discovering and delivering digital therapeutic and diagnostic devices to those suffering from pelvic floor disorders. Throughout his long career, beer held a number of roles in companies that are part of the healthcare sector.

 

In 2000, Beer took on the role of Founding Chief Executive Officer at ViaCell – a biotech company that was focusing on umbilical cord blood stem cells. His role lasted seven years, leading the company from its inception through a phase of rapid growth. Under his leadership, ViaCell had 300 employees, and went public in 2005. The company ended up being acquired afterwards by PerkinElmer, in 2007. Beer also played a role at Genzyme in the sales and marketing department, was part of the diagnostic divisions at Abbott Laboratories, and was a member of the Mass Life Science Board at the Commonwealth of Massachusetts. Learn more: https://www.crunchbase.com/person/marc-beer

Nitin Khanna a Portland Based Serial Entrepreneur

The Silicon Forest is used to big exits however in the lasted decade it has recorded very few exits, and one of them is the acquisition of Saber Corps. Saber Corps was founded by Merger Tech Owner and CEO Nitin Khanna way back in 2009. The Portland-based company had been contracted by the US government to provide some of the government services to the members of the public. The state government services include vehicle registration, issuance of driver licenses and registration of those that are unemployed among others as detailed here.

Saber Corps first acquisition took place in the year 2007 when EDS purchased the firm at a tune of 420 million dollars. Nitin Khanna after the firm’s acquisition continued serving as the firm CEO. Saber Corp a year later was naturally absorbed by HP Company after it acquired EDS. After the purchase of EDS by HP, Nitin Khanna opted to leave the firm and pursue other entrepreneur interests.

Nitin Khanna, an entrepreneur at heart, established another firm together with his brother known as MergerTech. MergerTech is an investment bank that is headquartered in California. The firm focuses on providing capital and offering buyout deals to early-stage firms including small businesses that are worth less than 100 million dollars. Nitin Khanna will serve as the firm’s CEO and will run the business while in Portland. Nitin Khanna’s brother will serve as Merger Tech COO and will be the one carrying out the business operations in California.

Nitin Khanna is optimistic that the new investment will have a substantial market for its services. The niche that Merger Tech chose is free from completion from big investment banks that targets big businesses. According to Nitin Khanna, Merger Tech considers three factors when selecting potential clients. One of the things that they look out for is businesses that are in distress and are seeking for a fast buyout deals to salvage investors equity. The second category of business that Merger Tech deals with is those companies that are growing and are look for investors. Lastly, Merger Tech looks for mature startups that want to exit.

More about his latest ventures can be read via this link https://medium.com/@NitinKhannaCeo/nitin-khanna-riding-the-cannabis-wave-with-cura-cannabis-solutions-9fcf612ee529

 

Email Him And They Will Come

To understand emails all you have to do is send and receive, but to get more technical with marketing efforts your going to need CEO Krishen Iyer to do the job right. Krishen Iyer’s company specializes in marketing services for health and insurance companies that wants to expand their lead generation services and consulting opportunities. It may seem out of the ordinary, but taking advantage of the industry leaves a great opportunity to forward such industries. These companies need a system for newsletters and updates to send out to their subscribers. I’m sure we both have seen a few of our emails filled with news on our next visit to the Doc’s office. However, in order for these emails to get open there are a few rules needed to be followed for us to get attentive to reading about our medical issues we pretend don’t exist. Read more about email marketing here.

Yet, Krishen Iyer has light for all of us with his company “Managed Benefit Services” they use techniques and email analytical tools to determine the best outcomes so we don’t forget to stay healthy and help our fellow insurance companies waste revenue and put it to good use. As a marketing expert Krishen Iyer’ need for multiple marketing streams to emerge from new organic traffic is a death toll to gaining the results they need because only one source will not produce the results industry leaders need for a more proficient business and ethical service to the clients they provide services for.

Kristen Iyer plans for his companies ability to identify “ cost per acquisition needs “ and special factors customers require. In the end result his plan is for his system to make it easy for customers to filter these essential components that demonstrate his companies competitive cost. As a determined entrepreneur any insurance company or medical firm wanting a taste of increase in their firms value should contact him not by call but by email. As we have already investigated in this article he knows his emails and I’m sure he will know what to say and do upon the first message when you hit send.

Get to know Krishen Iyer on https://www.xing.com/profile/Krishen_Iyer

“Marc Beer Launches a New Product for Pelvic Disorders “

Marc Beer is a well -known businessman who plays an important role in the healthcare industry. He mainly ventures in the sector as he aims at improving the health of the most vulnerable group in the world, the women. Primarily beer is concerned with the health status of women in Dallas. He owns one of the most reputable pharmaceutical companies known as Renovia Inc. which manufactures pharmaceutical and other diagnostic products which are used in the treatment of pelvic disorders in women.

 

Pelvic disorders such as urinary incontinence and many others are conditions which affect most women in the world. Marc beer tries his level best in alleviating this menace and help women live happily. His company is based in Houston, and he founded it in the year 2015. It is a highly prolific company which has produced a product already in the market known as Leva. The product helps in treating the conditions and bringing desired results. it is accredited and approved by FDA. Even though Marc Beer is not a health professional, but he has many years of experience working in commercializing and developing the pharmaceutical and biotechnology industry. Before founding his pharmaceutical firm, he

was the Chief Executive Officer at Aegerion Pharmaceuticals.

 

Marc Beer was born In Dallas, Texas and attended the University of Miami in Ohio State where he graduated with a bachelor’s degree in business administration. He has been practicing his career for over 25 years, and indeed he performs excellently anywhere he works. He has worked in a number of companies in the US such as Viacell Inc. where he served as the Chief Executive Officer. Between 1996 and 2000, Marc used to be the vice president of Global marketing at Sanofi Pharmaceuticals. He also worked at Genzyme Corporation as the Vice President, and Biostar was the president of sales and marketing.

 

Marc Beer has worked as a member of the board of directors and consultant at OVAS Company and Private Life Science Companies. He has been the director of the Cytopherx Company and the Good Start Genetics. He is really experienced in managing companies, and this enabled how to be in a position to launch his company and runs it smoothly.

 

His Boston based company plans to launch a new product to help in treating pelvic disorders for women. The company has raised over $42 billion to assist in undertaking the project which helps in boosting the health status of the women especially women in Dallas. Marc beer is the leader of the product and besides he plans to introduce other four products to treat the conditions. He tries to give back to the community by helping them improve their health status. Learn more: https://www.cnbc.com/video/2013/01/23/aegerion-ceo-on-promise-of-biopharma.html